Concepedia

Timothy A. Yap

TA

143

Publications

15K

Citations

54

H-Index

2006

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Institute of Cancer Research

Royal Marsden NHS Foundation Trust

Royal Marsden Hospital

Dana-Farber Cancer Institute

Timothy A. Yap is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2006–2025

143

Publications

143

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in <i>BRCA</i> Carrier Ovarian Cancer Correlating With Platinum-Free Interval

Peter C.C. Fong, Timothy A. Yap, David S. Boss et al. · Journal of Clinical Oncology · 2010 · 984 citations · Full text

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

Gerhardt Attard, Alison Reid, Timothy A. Yap et al. · Journal of Clinical Oncology · 2008 · 893 citations · Full text

PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness

Jianfeng Shen, Wei Zhao, Zhenlin Ju et al. · Cancer Research · 2018 · 561 citations · Full text

First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors

Timothy A. Yap, Yan Li, Amita Patnaik et al. · Journal of Clinical Oncology · 2011 · 539 citations

Rows per page

1–5 of 143